This compound is a salt form of the alogliptin pharmaceutical intermediate, consisting of a benzonitrile derivative with a stereochemically defined aminopiperidine substituent, co-crystallized with benzoic acid.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1638544-63-4
4-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile
research compound
Alogliptin Impurity 70
pharmaceutical intermediate
(S)-Alogliptin Benzoate Salt
pharmaceutical raw material
Propoxyphene hydrochloride
pharmaceutical raw material
Valbenazine ditosylate
pharmaceutical raw material
OCLACITINIB MALEATE
pharmaceutical raw material
Trelagliptin
pharmaceutical raw material
Trelagliptin succinate
pharmaceutical raw material
4-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile;benzoic acid
RDDTZEOYEAADOY-XFULWGLBSA-N
CN1C(=O)C=C(N(C1=O)CC2=CC=C(C=C2)C#N)N3CCC[C@H](C3)N.C1=CC=C(C=C1)C(=O)O
—